Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Charlotte Kristiansen, Miroslaw Stelmach, Eric Santoni-Rugiu, Maiken Parm Ulhøi, Betina Højgaard, Morten Sall Jensen, Anders Bondo Dydensborg*, Christina Dünweber, Karin Holmskov Hansen

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

Original languageEnglish
Article numberLMT68
Number of pages11
JournalLung Cancer Management
Volume13
Issue number1
DOIs
Publication statusPublished - 2024

Bibliographical note

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Fingerprint

Explore the research areas of 'Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis'.

Cite this